Raymond James Financial’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.98M Sell
317,434
-10,771
-3% -$334K ﹤0.01% 2026
2025
Q4
$9.14M Sell
328,205
-118,720
-27% -$3.56M ﹤0.01% 2046
2025
Q3
$13.4M Sell
446,925
-7,492
-2% -$211K ﹤0.01% 1697
2025
Q2
$13M Buy
454,417
+24,935
+6% +$742K ﹤0.01% 1677
2025
Q1
$14.2M Buy
429,482
+2,060
+0.5% +$67.2K 0.01% 1551
2024
Q4
$12.3M Buy
+427,422
New +$12.3M ﹤0.01% 1676

Other funds holding ALKS

Raymond James Financial's ALKS Position: Q1 2026 in Review

Raymond James Financial reduced its Alkermes (ALKS) stake by 3.3% in Q1 2026, selling an estimated $334K and leaving 317,434 shares worth $9.98M. The position accounts for ﹤0.01% of the portfolio, ranked #2026.

Raymond James Financial first reported a position in ALKS in Q4 2024 and has held it in 6 quarters since. The position peaked at $14.2M in Q1 2025. 389 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

  • Raymond James Financial held 317,434 shares of Alkermes worth $9.98M as of Q1 2026.
  • Raymond James Financial sold 10,771 Alkermes shares in Q1 2026, an estimated $334K.
  • Alkermes made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #2026 holding.
  • Raymond James Financial first reported a position in Alkermes in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Alkermes position peaked at $14.2M in Q1 2025.
  • 389 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.